111
Views
13
CrossRef citations to date
0
Altmetric
Research Article

From Cloning to a Commercial Realization: Human Alpha Interferon

&
Pages 179-190 | Published online: 27 Sep 2008

References

  • Isaacs A., Lindeman J. Virus interference. I. The interferon. Proc. R. Soc. Lond. Ser. B 1957; 147: 258
  • Isaacs A., Lindeman J., Valentine R. C. Virus interference: II. some properties of interferon. Proc. R. Soc. Lond. Ser. B 1957; 147: 268
  • Stewart W. E., II, Blalock J. E., Burke D. C., Chany C., Dunnick J., Falcoff E., Friedman R. M., Galasso G. J., Joklik W. K., Vilcek J. T., Youngner J. S., Zoon K. C. Interferon nomenclature. Nature 1980; 286: 110
  • Zoon K. C. Human interferons: structure and function. Interferon, I. Gresser. Academic Press, New York 1987; Vol. 9: 1
  • Neumann C. Mononuclear phagocytes as producers of interferon. Lymphokines 1982; 7: 165
  • Svet Moldavski G. J., Nemiroskaya B. M., Sipova O. T. V. Interferogenicity and antigen recognition. Nature 1974; 247: 205
  • Vilcek I., Sulea I. T., Volvovitz F., Lip Y. K. Characteristics of interferons produced in cultures of human lymphocytes by stimulation with Corynebacterium parvum and phytohaemaglutinin. Biochemical Characterization of Lymphokines, E. De Wick. Academic Press, New York 1980; 323
  • Machara N., Ho M. Cellular origin of Interferon induced by bacterial lipopolysaccharide. Infect. Immun 1977; 15: 78
  • Smith E. M., Johnson H. M., Blalock J. E. Staphylococcus aureus protein A induced the production of interferon-α in human lymphocytes and Interferon-α and β in mouse spleen cells. J. Immunol 1983; 130: 773
  • Ha veil E. A., Berman B., Ogburn C. A., Berg K., Paucker J., Vilcek J. Two antigenically distinct species of human interferons. Proc. Natl. Acad. Sci. U.S.A 1975; 72: 2185
  • Archer D. L., Smith B. G., Ulrich J. T., Johnson H. M. Immune interferon induction by T-cell mitogens involves different T-cell subpopulation. Cell. Immunol 1979; 48: 420
  • General considerations of the interferon system. The Interferon System: A Current Review to 1987, S. Baron, John G. Stanton, W. R. Fleischmann, Jr., F. Dianzani. University of Texas Press, Austin 1987; 1
  • Daugherty R., Martin-Zanca D., Kelder B., Collier K., Sea-Mans T. C., Hotta K., Pestka S. Isolation and bacterial expression of a murine alpha leukocyte interferon gene. J. Interferon Res 1984; 4: 635
  • Dijkema R., Pouwels P., de Reus A., Schellekens H. Structure and expression in Escherichia coli of a cloned rat interferon-alpha gene. Nucleic Acids Res 1984; 12: 1227
  • Lefevre P., LaBonnardiere C. Molecular cloning and sequencing of a gene encoding biologically active porcine alpha-interferon. J. Interferon Res 1986; 6: 349
  • Velan B., Cohen S., Grosfeld H., Shafferman A. Genetic and biological characterization of a bovine interferon-alpha gene family. Antiviral Res. 1984; 4: 61, (Spec. Issue)
  • The Interferon System: A Current Review to 1987, S. Baron, F. Dianzani, John G. Stanton, W. R. Fleischman, Jr. Texas University Press, Texas 1987
  • Stanton G. J., Baron S. Interferon and viral pathogenesis. Concepts in Viral Pathogenesis, A. L. Notkins, M. B. A. Olstone. Springer-Verlag, New York 1985
  • Billiau A. The interferon system as a basis for antiviral therapy of prophylaxis. Antiviral Res 1985; 1: 131
  • Peters M., Davis G. L., Doolery J. S., Hoofnagle J. H. The interferon system in acute and chronic viral hepatitis. Prog. Liver Dis 1986; 8: 453
  • Baron S., Weigent D. A., Stanton G. J., Peterson J. The protective role of endogenous interferon in viral bacterial, and protozoal infections. Antiviral Res 1985; 1: 173
  • Rossi G. B. Interferons and cell differentiation. Interferon 1985; 6: 31
  • Mannering G. J., Deloria L. B. The pharmacology and toxicology of the interferons: an overview. Annu. Rev. Pharmacol. Toxicol 1986; 26: 455
  • Krown S. E. Interferons and interferon inducers in cancer treatment. Semin. Oncol 1986; 13(Suppl. 2)207
  • Gresser I. How does interferon inhibit tumor growth?. Interferon 1985; 6: 93
  • Baron S., Grossberg G. R., Klimpel G. R., Brunell P. A. Immune and Interferon Systems. Antiviral Agents and Viral Diseases of Man, G. J. Galasso, T. C. Merigan, R. A. Buchanan. Raven Press. 1984; 123
  • Baron S., Fleischmann W. R., Jr., Klimpel G., Stanton G. J. Effects of virus induced interferons on the immune system. Viral Mechanisms of Immunosuppression, N. Gilmores, M. A. Wain-Berg. Alan R. Liss, New York 1985; 225
  • De Maeyer-Guignard J., DeMaeyer E. Immunomodulation by interferons: recent developments. Interferon 1985; 6: 31
  • Friedman R. M., Vogel S. N. Interferons with special emphasis on the immune system. Adv. Immunol 1983; 34: 97
  • Rubinstein M., Rubinstein S., Familleti P. C., Pestka S. Human leukocyte interferon: production purification to homogeneity, and initial characterization. Proc. Natl. Acad. Sci. U.S.A 1979; 76: 640
  • Zoon K. C., Smith M. E., Bridgen P. J., ZurNedden D., Anfinsen C. B. Purification and partial characterization of human lymphoblastoid interferons. Proc. Natl. Acad. Sci. U.S.A 1979; 76: 5601
  • Henco K., Brosius J., Fujisawa A., Fujisawa J.-I., Haynes J. R., Hochstadt J., Kovacic T., Pasek M., Schambock A., Schmid J., Todokoro K., Walchli M., Nagata S., Weiss-Mann C. Structural relationship of human interferon alpha genes and pseudogencs. J. Mol. Biol 1985; 185: 227
  • Levy W. P., Rubinstein M., Shivery J., Del Valle U., Lai C.-Y., Moschera J., Brink L., Gerber L., Stein S., Pestka S. Amino acid sequence of a human leucocyte interferon. Proc. Natl. Acad. Sci. U.S.A 1981; 78: 6186
  • Wetzel R. Assignment of the disulfide bonds of leukocyte interferon. Nature 1981; 289: 606
  • Labdon J. E., Gibson K. D., Sun S., Pestka S. Some species of human leukocyte interferon are glycosylated. Arch. Biochem. Bio-phys 1984; 232: 422
  • Nagata S., Taira H., Hall A., Johnsrud L., Streuli M., Ecsodi J., Boll W., Can tell K., Weissmann C. Synthesis in E. coli of a polypeptide with human leukocyte interferon activity. Nature 1980; 284: 310
  • Goeddel D. V., Yelverton E., Ullrich A., Heyneker H. L., Miozzari G., Holmes W., Seeburg P. H., Dull T., May L., Stebbing N., Crea R., Maeda S., McCandliss R., Sloma A., Tabor J. M., Gross M., Familletti P. C., Pestka S. Human leukocyte interferon produced by E. coli is biologically active. Nature 1980; 287: 411
  • Rubinstein M., Levy W. P., Moschera J. A., Lai C. Y., Hersh-Berg R. D., Bartlett R. T., Pestka S. Human leukocyte interferon: isolation and characterization of several molecular forms. Arch. Biochem. Biophys 1981; 210: 307
  • Allen G., Fantes K. H. A family of structural genes for human lymphoblastoid (leukocyte-type) interferon. Nature 1980; 287: 408
  • Feinstein S. J., Mory Y., Chernajovsky Y., Maroteaux L., Nir V., Lavie V., Revel M. Family of human α-interferon-like sequences. Mol. Cell. Biol 1985; 5: 510
  • Nagata S., Brack C., Henco K., Schambock A., Weissmann C. Partial mapping of ten genes of the human Interferon-α family. J. Interferon Res 1981; 1
  • Brack C., Nagata S., Mantei N., Weissmann C. Molecular analysis of the human interferon-α gene family. Gene 1981; 15: 379
  • Ullrich A., Gray A., Goeddel D. V., Dull T. J. Nucleotide sequence of a portion of human chromosome 9 containing a leukocyte interferon gene cluster. J. Mol. Biol 1982; 156: 467
  • Slate D. L., D'Eustachio P., Pravtcheva D., Cunningham A. C., Nagata S., Weissmann C., Ruddle F. H. Chromosomal location of a human α-interferon gene family. J. Exp. Med 1982; 155: 1019
  • Wilson V., Jeffreys A. J., Barrie P. A., Boseley P. G., Slocombe P. M., Easton A., Burke D. C. A comparison of vertebrate interferon gene families detected by hybridization with human interferon DNA. J. Mol. Biol 1983; 166: 457
  • Nagata S., Mantei N., Weissmann C. The structure of 1 of the 8 or more distinct chromosomal genes for human interferon alpha. Nature 1980; 287: 401
  • Trent J. M., Olson S., Lawn R. M. Chromosomal localization of human leukocyte, fibroblast, and immune interferon genes by means of in situ hybridization. Proc. Natl. Acad. Sci. U.S.A 1982; 79: 7809
  • Capon D. J., Shepard H. M., Goeddel D. V. Two distinct families of human and bovine interferon-a genes are coordinately expressed and encode functional polypeptides. Mol. Cell. Biol 1985; 5: 768
  • Ragg H., Weissmann C. Not more than 117 base pairs of 5′ flanking sequence are required for inducible expression of a human IFN-α gene. Nature 1983; 303: 439
  • Pestka S., Hotta K., Monahan J., Collier K. J. (1985) Detection of human leukocyte interferon αA and α2 genes in genomic DNAs by the use of deoxyoctadecyloligonucleotide probes. Abstracts of 1985 TNO-ISIR Meeting. 1985. Clearwater Beach, Florida, 5
  • Pestka S. Interferon: from rarity to plenty, simplicity to complexity. Recombinant Lymphokines and Their Receptors, S. Gillis. Marcel Dekker, Inc., New York 1987
  • Nagabhushan T. L., Leibowitz P. J. Recombinant DNA technology and characterization of recombinant alpha-2 interferon. Interferon alpha-2: Pre-Clinical and Clinical Evaluation, D. L. Kisner, J. F. Smyth. Martinuss Nijhoff Publishers, Boston 1985
  • Laplace F., Hartmann M., Klessen C., Tonew M., Malke H. Expression of the human interferon-alpha 1 gene under transcriptional and translational control of the speA gene. J. Basic Microbiol 1988; 28: 55
  • Feinstein S. I., Chernajovsky Y., Chen L., Maroteaux L., Mory Y. Expression of human interferon genes using the recA promoter of, Escherichia coli. Nucleic Acids Res 1983; 11: 2927
  • Miyake T., Oka T., Nishizawa T., Misoka F., Fnwa T., Yoda K., Yamasaki M., Tamura G. Secretion of human interferon-alpha induced by using secretion vectors containing a promoter and signal sequence of alkalne phosphatase EC-3.1.3.1 gene of, Escherichia coli. J. Biochem. (Tokyo) 1985; 97: 1429
  • Barbero J. L., Buesa J. M., Penalva M. A., Perez-Aranda A., Garcia J. L. Secretion of mature human interferon-alpha-2 into the periplasmic space of, Escherichia coli. J. Biotechnol 1986; 4: 255
  • Shchelkunov S. N., Il'Ichev A. A., Krasnykh V. N., Timofeev I. V., Ryazankin I. A., Yamshchikov V. E., Popov S. G. Increasing the yield of interferon in Escherichia coli cells by using signal peptide construction. Biotekhnologiya 1987; 2: 146
  • Windass J. D., Newton C. R., De Maeyer-Guignard J., Moore V. E., Markham A. F., Edge M. D. The construction of a synthetic Escherichia coli trp promoter and its use in the expression of a synthetic interferon gene. Nucleic Acids Res 1982; 10: 6639
  • Grundstrum T., Von Gabain A., Nilsson G., Andersson M., Lundstrom H., Lund B., Lundgren E. Expression of an interferon-alpha gene variant in E. coli using tandemly repeated synthetic ribosomal binding sites. DNA 1987; 6: 41
  • Shepard H. M., Yelverton E., Goeddel D. V. Increased synthesis in E. coli of fibroblast and leukocyte interferons through alterations in ribosome binding sites. DNA 1982; 1: 125
  • Kitano K., Fujimoto S., Nakao M., Watanabe T., Nakao Y. Intracellular degradation of recombinant proteins in relation to their location in, Escherichia coli cells. J. Biotechnol 1987; 5: 77
  • Klyachko E. V., Lysenko E. S., Bremashvili M. R., Kozlov Yu. I., Strongin A. Ya, Shakulov R. S. Mutations in PNP and HTP-R genes stabilize the products of foreign gene expression. Mol. Biol 1988; 22: 760
  • Palva I., Lehtovaara P., Kaariainen L., Sibakov M., Cantell K., Schein C. H., Kashiwagi K., Weissmann C. Secretion of interferon by, Bacillus subtilis. Gene 1983; 22: 229
  • Krasnykh V. N., Danilyuk N. K., Il'ichev A. A., Gorbunov Yu. A., Lomakin A. I., Sinyakov A. N., Vtorushina I. A., Yastrebov S. I., Popov S. G., et al. Chemical-enzymic synthesis and cloning of the Bacillus amyloliquefaciens alpha.-amylase signal peptide for expresson of the synthetic. alpha.2 human interferon gene. Biotekhnologiya 1988; 4: 609
  • Pulido D., Vara J. A., Jimenez A. Cloning and expression in biologically active form of the gene for human interferon alpha 2 in, Streptomyces lividans. Gene 1986; 45: 167
  • Kalinin T. Yu, Vorob'Ev A. A., Parfenov V. V., Titushkina T. D., Fridman Ya A., Andreev V. A., Yanulaitis A. A., Bumyalis V., Marchenko V. I. Experimental preclinical study of human interferon obtained by genetic engineering on the basis of the recombinant clones of Escherichia coli 74 and pseudomonas-SP VG-84. Zh. Mikrobiol Epidemiol Immunobiol 1985; 0(10)3
  • Chistoserdov A., Eremashvili M. R., Mashko S. V., Lapidus A. L., Skvortsova M. A. Expression of the human interferon alpha F gene in the obligate methylotroph methylocacillus flagellatum KT and, Pseudomonas putida. Mol Gen. Mikrobiol Virosol 1987; 8: 36
  • Band L., Henner D. J. Bacillus subtilis requires a “stringent” shine-dalgarno region for gene expression. DNA 1984; 3: 17
  • Hitzeman R. A., Hagie F. E., Levine H. L., Goeddel D. V., Ammerer G., Hall B. D. Expression of a human gene for interferon in yeast. Nature 1981; 293: 717
  • Tuite M. F., Dobson M. J., Roberts N. A., King R. M., Burke D. C., Kingsman S. M., Kingsman A. J. Regulated high efficiency expression of human interferon-alpha in, Saccharomyces cerevisiae. EMBO J 1982; 1: 603
  • Mellor J., Dobson M. J., Roberts N. A., Kingsman A. J., Kingsman S. M. Factors affecting heterologous gene expression in, Saccharomyces cerevisiae. Gene 1985; 33: 215
  • Bitter G. A., Kevin M. E. Expression of heterologous genes in Saccharomyces cerevisiae from vectors utilizing the glyceraldehyde-3-phosphate dehydrogenase gene promoter. Gene 1984; 32: 263
  • Singh A., Lugovoy J. M., Kohr W. J., Perry L. J. Synthesis, secretion and processing of α-factor-interferon fusion proteins in yeast. Nucleic Acids Res 1984; 12: 8927
  • Uchlda Y., Kaneda T., Nagai M., Arimura H. JP Patent. 88160587 A2, A novel mammalian cell expression vector containing SV40 early promoter and human Ig heavy chain enhancer, and its use for manufacturing heterologous proteins. JP Patent 63160587, 1988
  • Derynck R., Gray P. W., Yelverton E., Leung D. W., Shepard H. M., Lawn R. M., Ullrich A., Najarian R., Pennica D., Hagie F. E., Hitzeman R. A., Sherwood P. J., Levinson A. D., Goeddel D. V. Synthesis of human interferons and analogs in heterologous cells. From Genes to Protein: Translation into Biotechnology, F. Ahman, J. Schultz, E. E. Smith, W. J. Whelan. Academic Press, New York 1982; 249
  • Maeda S., Kawai T., Obinata M., Fujiwara H., Horichi T., Sacki Y., Furusawa M. Production of human alpha-interferon in silk worm using a baculovirus vector. Nature 1985; 315: 592
  • Streu H. M., Hall A., Boll W., Stewart W. E., II, Nagata S., Weissmann C. Target cell specificity of 2 species of human interferon alpha produced in Escherichia coli and of hybrid molecules derived from them. Proc. Natl. Acad. Sci. U.S.A 1981; 78: 2848
  • Week P. K., Apperson S., Stebbing N., Gray P. W., Leung D., Shepard H. M., Goeddel D. V. Antiviral activities of hybrids of two major human leukocyte inerferons. Nucleic Acids Res 1981; 9: 6153
  • Franke A. E., Shepard H. M., Houck C. M., Leung D. W., Goeddel D. V., Lawn R. M. Carboxyterminal region of hybrid leukocyte interferons affects antiviral specificity. DNA 1982; 1: 223
  • Raj N. B., Israeli R., Kelley K. A., Leach S. J., Minasian B., Sikaris K., Parry D. A., Pitha P. M. Synthesis, antiviral activity, and conformational characterization of mouse-human alpha-interferon hybrids. J. Biol. Chem 1988; 263: 8943
  • Edge M. D., Greene A. R., Heathcliffe G. R., Meacock P. A., Schuch W., Scanlon D. B., Atkinson T. C., Newton C. R., Markham A. F. Total synthesis of a human leukocyte interferon gene. Nature 1981; 292: 756
  • Edge M. D., Greene A. R., Heathcliffe G. R., Moore V. E., Faulkner N. J., Camble R., Petter N. N., Trueman P., Schuch W., Hennam J., Atkinson T. C., Newton C. R., Markham A. F. Chemical synthesis of a human interferon-α2 gene and its expression in, Escherichia coli. Nucleic Acids Res 1983; 11: 6419
  • De Maeyer E., Skup D., Prasad K. S. N., De Maeyer-Guignard J., Williams B., Meacock P., Sharpe G., Pioli D., Hennam J., Schuch W., Atherton K. Expression of a chemically synthesized human al interferon gene. Proc. Natl Acad. Sci. U.S.A 1982; 79: 4256
  • Windass J. D., Newton C. R., De Maeyer-Guignard J., Moore V. E., Markham A. F., Edge M. D. The construction of a synthetic Escherichia coli trp promoter and its use in the expression of a synthetic interferon gene. Nucleic Acids Res 1982; 10: 6639
  • Moore V. E., Camble R., Edge M. D. Properties of interferon-alpha-2 analogues produced from synthetic genes. Br. J. Cancer 1986; 53: 420
  • Klein M. L., Bartley T. D., Lai P. H., Lu H. S. Structural characterization of recombinant consensus interferon-alpha. J. Chromatogr 1988; 454: 205
  • Lee N., Zheng S. U., Consitorto J., Yang J. S., Testa D. Modification of mRN A secondary structure and alteration of the expression of human interferon alpha 1 in, Escherichia coli. Gene 1987; 1: 77
  • Cho N., Chong I., Kim C., Kim H., Yu M. Mutagenesis of alpha interferon produced by genetically altered, Escherichia coli. Korean J. Appl. Microbiol. Bioeng 1986; 14: 520
  • Camble R., Petter N. N., Trueman P., Newton C. R., Carr F. J., Hockney R. C., Moore V. E., Greene A. R., Holland D., Edge M. D. Functionally important conserved amino acids in Interferon-α2 identified with analogs produced from synthetic genes. Biochem. Biophys. Res. Commun 1986; 134: 1404
  • Valenzuela D., Weber H., Weissmann C. Is sequence conservation in interferons due to selection for functional proteins?. Nature 1985; 313: 698
  • Cantell K., Hirvonen S. Large-scale production of human leukocyte interferon containing 10(8) units per ml. J. Gen. Virol 1978; 39(3)541
  • Kuitang T., Lun X., Junzi L., Meiping Z., Wei T., Yunde H. High Density fermentation of E. coli harboring human alpha-1 interferon. J. Interferon Res 1988; 8: 153
  • Hochuli E. Large-scale recovery of Interferon α-2a Synthesized in Bacteria. Chimia 1986; 40: 408
  • Leibowitz P., et al. U.S. Patent. 4, 315, 852, 1982, issued to P. Leibowitz et al.
  • Nagabhushan T. L., Suprenant H., Le H. V., Kosecki R., Reichert P., Sharma B., Tsai H., Trotta P., Bausch J., Foster C., Levine A., Gruber S., Hoogerheide J., Mercorelli S. Characterization of Genetically Engineered Alpha-2 Interferon. Interferon: Research, Clinical Applications, and Regulatory Consideration. Elsevier, Amsterdam 1984; 79
  • Langer J. A., Pestka S. Purification, bacterial expression, and biological activities of the human interferons. J. Invest. Dermatol 1984; 83: 128
  • Pestka S., Langer J. A., Zoon K. C., Samuels C. E. Interferons and their actions. Annu. Rev. Biochem 1987; 56: 727
  • Methods in Enzymology, 79 Part A, S. Pestka. Academic Press, New York 1981; 677
  • Methods in Enzymology, 119 Part C., Interferons, S. Pestka. Academic Press, New York 1986; 845
  • Staehelin T., Durrer B., Schmidt J., Takacs B., Stocker J., Miggiano V., Stahli C., Rubenstein M., Levy W. P., Hershberg R., Pestka S. Production of hybridomas secreting monoclonal antibodies to the human leukocyte interferons. Proc. Natl. Acad. Sci. U.S.A 1981; 78: 1848
  • Staehelin T., Hobbs D. S., Kung H. F., Lai C. Y., Pestka S. Purification and characterization of recombinant leukocyte interferon (IFLrA) with monoclonal antibodies. J. Biol. Chem 1981; 256: 9750
  • Tarnowski S. J., Liptak R. A. Advances in Biotechnological Processes, A. Mizrahi, A. L. van Wezel. Alan R. Liss, New York 1983; Vol. 2: 271
  • Arnheiter H., Thomas R. M., Leist T., Fountoulakis M., Gutte B. Physicochemical and antigenic properties of synthetic fragments of human leukocyte interferon. Nature 1981; 294: 278
  • Arnheiter H., Ohno M., Smith M., Gutte B., Zoon K. C. Orientation of human leukocyte interferon molecule on its cell surface receptor: Carboxyl terminus remains accessible to monoclonal antibody made against a synthetic interferon fragment. Proc. Natl. Acad. Sci. U.S.A 1983; 80: 2539
  • Ackerman S. K., Zur Nedden D., Heintzelman M., Hunkapiller M., Zoon K. Biological activity in a fragment of recombinant and human leukocyte. Proc. Natl. Acad. Sci. U.S.A 1984; 81: 1045
  • Brunt J. V. Interferon trials proliferate. Biotechnology 1989; 7: 549
  • Trotta P., personal communication, Schering-Plough Research
  • Bordens R., personal communication, Schering-Plough Research
  • Bausch J., personal communication, Schering-Plough Research

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.